NEWS & EVENTS
PRESS RELEASES 2006
ELUSYS ANNOUNCES FALL 2006 CONFERENCE SCHEDULE
PINE BROOK, NJ – October 16, 2006 – Elusys Therapeutics, Inc., a developer of targeted anti-infective therapeutics, today announced its fall conference schedule which will include presentations at Biotech 2006: Imagine. Collaborate. Innovate conference, BIO InvestorForum 2006, Mass Biotech Council’s 8th Annual Mass Opportunities, Rodman and Renshaw’s 8th Annual Healthcare Conference and BIO-Europe 2006.
Elizabeth Posillico, Ph.D., President and Chief Executive Officer, and George Elston, Vice President of Finance and Government Affairs, will both be panelists at Biotechnology Council of New Jersey and Pennsylvania Bio’s Biotech 2006: Imagine. Collaborate. Innovate Conference. The conference will be held on October 16-17, 2006, at the Loews Philadelphia Hotel in Philadelphia, PA. Dr. Posillico will be featured on the early-stage session III panel entitled, “Raising Money & Conquering the Funding Process,” on Monday, October 16, 2006, from 12:30-2:00 P.M. Mr. Elston will be featured on the mid-stage session I panel entitled, “Building a Scalable Management Infrastructure,” on Monday, October 16, 2006, from 8:30-10:00 A.M. For more information please visit: www.biotech2006.org.
Dr. Posillico will present at BIO InvestorForum 2006 taking place October 17-19, 2006 in San Francisco, CA, at the Palace Hotel. She will present on Thursday, October 18, 2006 at 4:20 P.M. in the Pacific Heights room and will be available for one-on-one meetings during the conference. For more information please visit: http://investorforum.bio.org/opencms/bif/2006/index.jsp.
Dr. Posillico will present at Mass Biotech Council’s 8th Annual Mass Opportunities being held on November 2, 2006 at the Hilton Logan Airport Hotel in Boston, MA. She will present a corporate overview and will be available for one-on-one meetings during the meeting. For more information please visit: http://www.massbio.org/events/mass_opps/.
Dr. Posillico will present at Rodman and Renshaw’s 8th Annual Healthcare conference in New York being held November 6-8, 2006 at the New York Palace Hotel. Her presentation will take place on Tuesday, November 7, 2006 at 4:15 P.M. in the Spellman room, 5th floor and she will be available for one-on-one meetings during the conference. For more information please visit:
http://www.rodmanandrenshaw.com.
Mr. Elston will present at BIO-Europe 2006 being held in Duesseldorf, Germany, November 6-8, 2006 at the Congress Center. He will present a corporate overview on November 7, 2006 at 5:00 P.M. in Room 27, Level 2 of the Congress Center Sued and will be available for one-on-one meetings during the conference. For more information please visit:
http://www.ebdgroup.com/bioeurope/.
About Elusys
Elusys is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using proprietary Heteropolymer (HP) Antibodies. Visit www.elusys.com/technology-hp-overview.php for more information on the HP Antibody technology. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures and MedImmune Ventures.